CSI, Pain Relieving Gel-Patch, Lidocaine 4%, 5 Patches

Pain Relieving Gel-Patch by

Drug Labeling and Warnings

Pain Relieving Gel-Patch by is a Otc medication manufactured, distributed, or labeled by Shanghai Chuangshi Medical Technology (Group) Co., Ltd.. Drug facts, warnings, and ingredients follow.

Drug Details [pdf]

PAIN RELIEVING GEL-PATCH- lidocaine patch 
Shanghai Chuangshi Medical Technology (Group) Co., Ltd.

Disclaimer: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.

----------

CSI, Pain Relieving Gel-Patch, Lidocaine 4%, 5 Patches

Active ingredient

Lidocaine 4% ...... Purpose: Topical Anesthetic

Purpose

Topical Anesthetic

Uses

For temporary relief of pain

Warnings

For external use only

Ask a doctor if:

  • localized skin reactions occur, such as rash, itching, redness, irritation, pain, swelling and blistering
  • Conditions worsen
  • Symptoms persists for more than 7 days
  • Symptoms clear up and occur again within a few days

When using this product

  • Use only as directed
  • Avoid contact with the eyes, mucous membranes or rashed
  • Do not bandage tightly

Do not use

  • More than 1 patch at a time
  • On wounds or damaged skin
  • With a heating pad
  • If you are allergic to any ingredients of this product

Stop use if:

  • localized skin reactions occur, such as rash, itching, redness, irritation, pain, swelling and blistering
  • Conditions worsen
  • Symptoms persists for more than 7 days
  • Symptoms clear up and occur again within a few days

Pregnancy or breast feeding

If pregnant or breastfeeding, ask a health professional before use

Keep out of reach of children

Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.

Directions

Adult and Children 12 years of age and over:

  • Clean and dry affected area
  • Remove film from patch and apply to the skin (see illustration)
  • Apply 1 patch at a time to affected area, not more than 3 to 4 times daily
  • Remove patch from the skin after at most 8-hour application

Children under 12 years of age: Consult a doctor

Dosage forms & strengths

This is a strip, patch dosage form.

The active ingredient strength is 4% w/w.

One patch one time, no more than 8 hours one time.

Inactive ingredients

Glycerin, Sodium Polyacrylate, Dihydroxyaluminum Aminoacetate, Disodium Ethylenediaminetetraacetic Acid, Kaolin, Titanium Dioxide, Polysorbate 80, Propylene Glycol, Tartaric Acid, Polyacrylic Acid, Polyvinylpyrrolidone K90, Methylparaben, Propylparaben, Water

Questions

Questions or Comments: 86-21-31166566

Other information

  • Avoid storing product in direct sunlight
  • Protect product from excessive moisture

Package label. Principal display panel

155-01155-05

PAIN RELIEVING GEL-PATCH 
lidocaine patch
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC: 73557-156
Route of AdministrationTOPICAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
LIDOCAINE (UNII: 98PI200987) (LIDOCAINE - UNII:98PI200987) LIDOCAINE0.04 g  in 1 g
Inactive Ingredients
Ingredient NameStrength
POLYSORBATE 80 (UNII: 6OZP39ZG8H)  
GLYCERIN (UNII: PDC6A3C0OX)  
POVIDONE K90 (UNII: RDH86HJV5Z)  
METHYLPARABEN (UNII: A2I8C7HI9T)  
PROPYLPARABEN (UNII: Z8IX2SC1OH)  
EDETATE DISODIUM (UNII: 7FLD91C86K)  
KAOLIN (UNII: 24H4NWX5CO)  
TARTARIC ACID (UNII: W4888I119H)  
WATER (UNII: 059QF0KO0R)  
PROPYLENE GLYCOL (UNII: 6DC9Q167V3)  
POLYACRYLIC ACID (250000 MW) (UNII: 9G2MAD7J6W)  
SODIUM POLYACRYLATE (8000 MW) (UNII: 285CYO341L)  
TITANIUM DIOXIDE (UNII: 15FIX9V2JP)  
DIHYDROXYALUMINUM AMINOACETATE ANHYDROUS (UNII: 1K713C615K)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC: 73557-156-055 in 1 BOX05/28/202112/30/2022
1NDC: 73557-156-015.5 g in 1 PATCH; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC monograph not finalpart34805/28/202112/30/2022
Labeler - Shanghai Chuangshi Medical Technology (Group) Co., Ltd. (546872672)
Registrant - Shanghai Chuangshi Medical Technology (Group) Co., Ltd. (546872672)
Establishment
NameAddressID/FEIBusiness Operations
Shanghai Chuangshi Medical Technology (Group) Co., Ltd.546872672manufacture(73557-156) , label(73557-156)

Revised: 12/2022
 
Shanghai Chuang

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.